Index
Admin Log in
Search form
Home
Organizations
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.
Academic Article
Overview
authors
Lachin, John M
publication date
February 2018
published in
Diabetes Care
Journal